Global Empty Capsules for Medical Use Market Insights, Forecast to 2028

Empty capsules are things to store herbs, powders and medicines.
Market Analysis and Insights: Global Empty Capsules for Medical Use Market
Due to the COVID-19 pandemic, the global Empty Capsules for Medical Use market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Hard Gelatin Capsules (HGCs) accounting for % of the Empty Capsules for Medical Use global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Antibiotic & Antibacterial Drug segment is altered to an % CAGR throughout this forecast period.
China Empty Capsules for Medical Use market size is valued at US$ million in 2021, while the US and Europe Empty Capsules for Medical Use are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Empty Capsules for Medical Use landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Empty Capsules for Medical Use include ACG, Bright Pharma Caps, CapsCanada Corporation, Lonza Group Ltd., Medi-Caps Ltd., Mitsubishi Chemical Holdings, Roxlor LLC, Snail Pharma Industry and Suheung Co., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Empty Capsules for Medical Use Scope and Segment
Empty Capsules for Medical Use market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Empty Capsules for Medical Use market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Hard Gelatin Capsules (HGCs)
Soft Gelatin Capsules (SGCs)
Non-Gelatin Capsules
Segment by Application
Antibiotic & Antibacterial Drug
Vitamin & Dietary Supplement
Antacids & Anti-flatulent Preparation
Cardiac Therapy Drug
Other Applications
By Company
ACG
Bright Pharma Caps
CapsCanada Corporation
Lonza Group Ltd.
Medi-Caps Ltd.
Mitsubishi Chemical Holdings
Roxlor LLC
Snail Pharma Industry
Suheung Co.
Sunil Healthcare Ltd.
Capsugel
Qingdao Yiqing biological Polytron Technologies Inc
Capsuline
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Frequently Asked Questions